<qa>  What is the name of the patient who is enrolled in a concurrent drug andor- Patient is enrolled, has participated within the last thirty 30 days, or is planning to participate, in a concurrent drug andor device study during the course of this clinical trial. Co-enrollment in concurrent trials is only allowed with documented pre-approval from the Medtronic study manager that there is not a concern that co-enrollment could confound the results of this trial. 